Occult hepatitis B virus infection predicts de novo hepatitis B infection in patients with alcoholic cirrhosis after liver transplantation

Liver International

Volumn 35, Issue 3, 2015, Pages 897-904

  Xie, Man ^a   Rao, Wei ^b,c   Yang, Tao ^b,c   Deng, Yonglin ^b,c   Zheng, Hong ^b,c   Pan, Cheng ^b,c   Liu, Yihe ^b,c   Shen, Zhongyang ^b,c   Jia, Jidong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

^c Tianjin Key Laboratory of Organ Transplantation   (China)

Author keywords

Alcohol; Cirrhosis; de novo HBV infection; Hepatitis B virus infection; Orthotopic liver transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RAPAMYCIN; TACROLIMUS;

ADULT; ALCOHOL LIVER CIRRHOSIS; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; EXPLANT; FEMALE; GRAFT RECIPIENT; HEPATITIS B; HUMAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; CHINA; COMPLICATION; END STAGE LIVER DISEASE; LIVER CIRRHOSIS, ALCOHOLIC; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; VIROLOGY;

ADULT; CHINA; END STAGE LIVER DISEASE; FEMALE; HEPATITIS B; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84922609448     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12567     Document Type: Article

References (32)

1. O'Grady JG, Smith HM, Davies SE, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serologicaland clinical implications. J Hepatol 1992; 14: 104-11.
2. Todo S, Demetris AJ, Van Thiel D, et al. Orthotopic liver transplantation for patients with hepatitis B virus-relatedliver disease. Hepatology 1991; 13: 619-26.
3. Loomba R, Rowley AK, Wesley R, et al. Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis. Clin Gastroenterol Hepatol 2008; 6: 696-700.
4. Dodson SF, Bonham CA, Geller DA, et al. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999; 68: 1058-61.
5. Chazouilleres O, Mamish D, Kim M, et al. 'Occult' hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343: 142-6.
6. Liu CJ, Lo SC, Kao JH, et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatricrecipients in Taiwan. J Hepatol 2006; 44: 39-46.
7. Raimondo G, Caccamo G, Filomia R, Pollicino T. Occult HBV infection. Semin Immunopathol 2013; 35: 39-52.
8. Skagen CL, Jou JH, Said A. Risk of de novo hepatitis in liver recipients from hepatitis-B coreantibody-positive grafts - a systematic analysis. Clin Transplant 2011; 25: E243-9.
9. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat 2010; 17: 1-15.
10. Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol 2010; 52: 272-9.
11. Saab S, Waterman B, Chi AC, Tong MJ. Comparison of different immunoprophylaxis regimens after liver transplantationwith hepatitis B core antibody-positive donors: a systematic review. Liver Transpl 2010; 16: 300-7.
12. Shetty K, Hussain M, Nei L, Reddy KR, Lok AS. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Liver Transpl 2008; 14: 534-40.
13. Shouval D. What is the clinical significance of the high prevalence of occult hepatitis B in US liver transplant patients with chronic hepatitis C. Liver Transpl 2008; 14: 418-9.
14. Roche B, Samuel D, Gigou M, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997; 26: 517-26.
15. Ghisetti V, Marzano A, Zamboni F, et al. Occult hepatitis B virus infection in HBsAg negative patients undergoing livertransplantation: clinical significance. Liver Transpl 2004; 10: 356-62.
16. Abdelmalek MF, Pasha TM, Zein NN, et al. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure. Liver Transpl 2003; 9: 1253-7.
17. Hussain M, Soldevila-Pico C, Emre S, Luketic V, Lok AS. Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Liver Transpl 2007; 13: 1137-44.
18. Cheung CK, Lo CM, Man K, Lau GK. Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis. Liver Transpl 2010; 16: 1314-23.
19. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007; 46: 160-70.
20. Raimondo G, Navarra G, Mondello S, et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008; 48: 743-6.
21. Candotti D, Lin CK, Belkhiri D, et al. Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut 2012; 61: 1744-53.
22. Fang Y, Shang QL, Liu JY, et al. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect 2009; 58: 383-8.
23. Kwon OS, Jung YK, Bae KS, et al. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study. Alcohol 2012; 46: 537-41.
24. Wong DK, Huang FY, Lai CL, et al. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology 2011; 54: 829-36.
25. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology 2010; 51: 307-28.
26. Chen YS, Wang CC, de Villa VH, et al. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors. Clin Transplant 2002; 16: 405-9.
27. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479-86.
28. Shi Y, Wu YH, Wu W, et al. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Liver Int 2012; 32: 231-40.
29. Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G. Impact of Occult hepatitis B virus infection on the outcome of chronic hepatitis C. J Hepatol 2013; 59: 696-700.
30. Raimondo G, Cacciamo G, Saitta C. Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease. Ann Hepatol 2005; 4: 100-6.
31. Brechot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'. Hepatology 2001; 34: 194-203.
32. Zhong Y, Han J, Zou Z, et al. Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR. Clin Chim Acta 2011; 412: 1905-11.